🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cydney Nichols

Indiana University Health

ORCID: 0000-0003-4024-5339

Also affiliated with Riley Hospital for Children, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study”.

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379
N/A
0.286DataRank · unranked
4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

PI3K Targeting in Non-solid Cancer

Current topics in microbiology and immunology(2022)10.1007/978-3-031-06566-8_17
N/A
0.269DataRank · unranked
5 citations

Heather Ogana, Vanessa Edna Sanchez, Cydney Nichols, Yong‐Mi Kim, Hye Na Kim

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

Frontiers in Oncology(2021)10.3389/fonc.2021.766888
N/A
0DataRank · unranked
2 citations

Hye Na Kim, Heather Ogana, Zesheng Wan, Samantha Hurwitz, Cydney Nichols +14 more

Noncanonical microprotein regulation of immunity

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.021
N/A
0DataRank · unranked
6 citations

Van Anh Do-Thi, Daniel Peltier, Cydney Nichols